Taha Kass-Hout - Feb 1, 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role: Chief Technology Officer
Signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol: GEHC
Transactions as of: Feb 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/3/2023, 05:00 PM
Previous filing: Jan 11, 2023
Next filing: Mar 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GEHC	Common Stock, par value $0.01 per share	Award	$0	+6.61K		$0.00	6.61K	Feb 1, 2023	Direct	F1, F2
transaction	GEHC	Common Stock, par value $0.01 per share	Award	$0	+49.5K	+749.91%	$0.00	56.1K	Feb 2, 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GEHC	Employee Stock Option (right to buy)	Award		+58K			58K	Feb 1, 2023	Common Stock, par value $0.01 per share	58K	$70.01	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.
F2	Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3	Award of restricted stock units with respect to GE HealthCare common stock, of which 50% will vest on February 2, 2024 and 50% will vest on February 2, 2025.
F4	Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.